Background Prostate cancer (PCa) is an immune-responsive disease. The current study
sought to explore a robust immune-related prognostic gene signature for PCa. Methods …

Background: Immune-related genes possess promising prognostic potential in multiple
cancer types. Here, we describe the development of an immune-related prognostic …

Background There is significant heterogeneity in prostate cancer (PCa), but immune status
can reflect its prognosis. This study aimed to explore immune-related gene-based novel …

Purpose Prostate cancer (PCa) has a high incidence among older men. Until now, there are
no immunological markers available to predict PCa patients' survival. Therefore, it is …

Background: Decision-making regarding biochemical recurrence (BCR) in localized prostate
cancer (PCa) patients after radical prostatectomy (RP) mainly relies on clinicopathological …

Prostate cancer (PCa) is one of the most common malignancies in male. We aim to establish
a novel gene signature for immune infiltration and outcome (biochemical recurrence (BCR) …

Introduction: Prostate cancer (PCa) is the second most common malignancy in men. Despite
multidisciplinary treatments, patients with PCa continue to experience poor prognoses and …

The interaction between the immune cells and the host immune system with the tumor cells
is significantly associated with the initiation and progression of prostate adenocarcinoma …

Background Prostate cancer (PCa) is the second lethal heterogeneous cancer among males
worldwide, and approximately 20% of PCa patients following radical prostatectomy (RP) will …

Immune microenvironment of prostate cancer (PCa) is implicated in disease progression.
However, previous studies have not fully explored PCa immune microenvironment. This …